INFO60
SpotlightTopics60sNEWQuizLogin
IndiaAI & TechBusinessTechnologySportsEntertainmentHealthScienceWorld
INFO60

Know more. Read less. What matters, fast.

Company

  • About
  • Contact
  • Editorial Policy
  • Corrections
  • Our desks
  • Publishers

Legal

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Account

  • Delete Account
  • Spotlight
  • Quick Cards
  • Topics
  • Web Stories
  • Hindi News

Free. One email a day. Unsubscribe anytime.

Editions

  • India
  • United States
  • United Kingdom
  • Canada
  • Australia
  • UAE & Gulf
  • Singapore
  • Hindi
  • All countries
© 2026 Info60. All rights reserved.
Home›health›As India Battles Sickle Cell Disease, Odisha’s Screening Model Is Drawing Attention
health

As India Battles Sickle Cell Disease, Odisha’s Screening Model Is Drawing Attention

By Info60 India Desk•Summary of reporting by Republic World•15h ago•0 views•
As India Battles Sickle Cell Disease, Odisha’s Screening Model Is Drawing Attention
Sickle cell disease and thalassemia have remained a silent public health challenge in India for decades, particularly across tribal and remote regions where awareness and diagnosis continue to lag.
ONLY AVAILABLE IN PAID PLANS
Read Full Article

Share this story

Report an error

Up next

Related Stories

Temperament, childhood adversity may offer clues to psychiatric vulnerability: NIMHANS study

Temperament, childhood adversity may offer clues to psychiatric vulnerability: NIMHANS study

The Hindu

Virgo Horoscope Today, October 2, 2026

Virgo Horoscope Today, October 2, 2026

News 18

Numerology Horoscope Today, October 2, 2026: See What's In Store For You

Numerology Horoscope Today, October 2, 2026: See What's In Store For You

News 18

Live Chat: Top Doctors Explain How To Read Your HbA1c Test And Understand Diabetes Risk

Live Chat: Top Doctors Explain How To Read Your HbA1c Test And Understand Diabetes Risk

Times Now News

What human brain tissue transplanted into mice showed us - The Hindu

Google News

Comments (0)

Please login to comment

Login
💬

No comments yet. Be the first to comment!